Scientific Focus and Core Activities

EntreChem's work is centered on natural products, which historically have been one of the richest sources of pharmaceutical leads. The company applies a combination of approaches to unlock and expand the chemical space accessible from microbial metabolites:

• Combinatorial biosynthesis: manipulation of biosynthetic gene clusters in producing microorganisms to generate new analogues and structural variants of natural products that would be difficult or impossible to obtain through conventional chemical synthesis.

• Microbial fermentation and strain engineering: cultivation and genetic modification of actinomycetes and other microbial producers to yield bioactive scaffolds.

• Medicinal and synthetic chemistry: semi-synthetic modification of natural product scaffolds to optimize potency, selectivity, and drug-like properties.

• Screening and characterization: evaluation of compounds for biological activity against relevant disease targets, including cancer cells and microbial pathogens.

This integrated platform allows EntreChem to build proprietary compound collections and to advance selected molecules toward preclinical development.

Therapeutic Areas

EntreChem has historically concentrated its drug discovery efforts in areas where natural product chemistry offers strong advantages:

• Oncology: development of small-molecule compounds with anticancer activity, including agents derived from natural product families known for cytotoxic and antitumor properties.

• Anti-infectives: exploration of antibacterial and other anti-infective compounds, addressing the ongoing need for new molecules to combat resistant pathogens.

The company's most prominent research efforts have included work on mithramycin-related compounds and other polyketide-derived molecules, where biosynthetic engineering can produce improved analogues with refined pharmacological profiles compared to the parent natural products.

Products and Services

EntreChem offers a range of products and services that reflect its expertise in natural products and chemical biology:

• Natural product compound libraries: collections of novel and known natural products and their derivatives available for screening and research purposes.

• Custom synthesis and semi-synthesis: production of specific natural product scaffolds and their analogues for research and development partners.

• Biosynthetic and fermentation services: generation of microbial metabolites through fermentation and engineered biosynthetic pathways.

• Research compounds and reference standards: supply of characterized bioactive molecules for use in biological and pharmacological studies.

• Collaborative drug discovery: partnerships with pharmaceutical and biotechnology organizations to identify and develop new chemical entities, contributing both proprietary compounds and discovery expertise.

Research and Development Approach

The company's R&D model integrates academic-grade scientific rigor with a commercial orientation toward translational research. By maintaining ties to university research environments and building on accumulated knowledge of biosynthetic pathways, EntreChem is able to access producing organisms and gene clusters that form the basis of its discovery platform. The combination of genetic engineering, fermentation, and chemistry enables the company to diversify natural product scaffolds and to pursue molecules with improved therapeutic indices.

EntreChem's research has contributed to the scientific literature in the fields of natural product biosynthesis and medicinal chemistry, reflecting an involvement in both fundamental discovery and applied drug development.

Position in the Biotechnology Landscape

As a small, research-intensive biotechnology enterprise, EntreChem represents the type of specialized spin-off company that translates academic discoveries into commercial opportunities. Operating from Asturias, a region of Spain with a notable tradition in microbiology and natural product research, the company contributes to the broader Spanish and European biotechnology ecosystem.

Its niche focus on natural products and combinatorial biosynthesis distinguishes it from larger generalist biotech firms, allowing it to offer specialized capabilities and compounds that are valuable to partners in pharmaceutical discovery. By providing both finished research compounds and collaborative discovery services, EntreChem serves academic institutions, research organizations, and industry partners seeking access to natural-product-derived chemical diversity.

Summary

EntreChem, S.L. is a Spain-based biotechnology company specializing in the discovery and development of bioactive natural products and their derivatives. Through a platform that combines microbial fermentation, combinatorial biosynthesis, and medicinal chemistry, the company generates novel chemical entities with applications primarily in oncology and anti-infective therapy. Its offerings include natural product libraries, custom synthesis, biosynthetic services, and collaborative drug discovery partnerships, all built on a foundation of expertise in the chemistry and biology of microbial metabolites.